Perturbations of the AKT signaling pathway in human cancer

Oncogene

Volumn 24, Issue 50, 2005, Pages 7455-7464

  Altomare, Deborah A ^a   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

AKT PKB kinases; Human malignancy; Oncogenes; Targeted therapy; Tumor suppressor genes

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; EVEROLIMUS; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PACLITAXEL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B BETA; PROTEIN KINASE LKB1; TACROLIMUS; TAMOXIFEN; TEMSIROLIMUS; TUBERIN; VON HIPPEL LINDAU PROTEIN;

CANCER; CANCER THERAPY; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL INVASION; CELL MOTILITY; ENZYME ACTIVATION; FAMILIAL CANCER; GENE AMPLIFICATION; GENE MUTATION; HUMAN; METASTASIS; PATHOGENESIS; PHAKOMATOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; NEOPLASM INVASIVENESS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 27844445642     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209085     Document Type: Review

References (103)

1. Altomare DA, Tanno S, De Rienzo A, Klein-Szanto A, Skele KL, Hoffman JP and Testa JR. (2003). J. Cell. Biochem., 87, 470-476.
2. Altomare DA, Wang HQ, Skele KL, DeRienzo A, Klein-Szanto AJ, Godwin AK and Testa JR. (2004). Oncogene, 23, 5853-5857.
3. Altomare DA, You H, Xiao GH, Ramos-Nino ME, Skele KL, De Rienzo A, Jhanwar SC, Mossman BT, Kane AB and Testa JR. (2005). Oncogene, 24, 6080-6089.
4. Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, Danino M, Karlan BY, Slamon DJ, Lee SH, Kim HS, Park WS, Kim SY, Lee KY, Kim SH, Lee JY and Yoo NJ. (2003). Cancer Res., 63, 196-206.
5. Arranz E, Robledo M, Martinez B, Gallego J, Roman A, Rivas C and Benitez J. (1996). Cancer Genet. Cytogenet., 87, 1-3.
6. Astrinidis A and Henske EP. (2005). Oncogene Rev., 24, 7475-7481.
7. Bacus SS, Altomare DA, Lyass L, Chin DM, Farrell MP, Gurova K, Gudkov A and Testa JR. (2002). Oncogene, 21, 3532-3540.
8. Balsara BR, Pei J, Mitsuuchi Y, Page R, Klein-Szanto AJ, Wang H, Unger M and Testa JR. (2004). Carcinogenesis, 25, 2053-2059.
9. Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Benedetti Panici P, Mancuso S, Neri G and Testa JR. (1995). Int. J. Cancer, 64, 280-285.
10. Bellacosa A, Kuman CC, Di Cristofano A and Testa JR. (2005). Adv. Cancer Res., 94, 29-86.
11. Bellacosa A, Testa JR, Staal SP and Tsichlis PN. (1991). Science, 254, 274-277.
12. Beuvink I, Boulay A, Fumagalli S, Zibermann F, Ruetz S, O'Reilly T, Natt F, Hall J, Lane HA and Thomas G. (2005). Cell, 120, 747-759.
13. Bjornsti MA and Houghton PJ. (2004). Cancer Cell, 5, 519-523.
14. Boudeau J, Sapkota G and Alessi DR. (2003). FEBS Lett., 546, 159-165.
15. Boulay A, Zumstein-Mecker S, Stephan C, Beuvink I, Zilbermann F, Haller R, Tobler S, Heusser C, O-Reilly T, Stolz B, Marti A, Thomas G and Lane HA. (2004). Cancer Res., 64, 252-261.
16. Brazil DP, Yang ZZ and Hemmings BA. (2004). Trends Biochem. Sci., 29, 233-242.
17. Brognard J, Clark AS, Ni Y and Dennis PA. (2001). Cancer Res., 61, 3986-3997.
18. Byun DS, Cho K, Ryu BK, Lee MG, Park JI, Chae KS, Kim HJ and Chi SG. (2003). Int. J. Cancer, 104, 318-327.
19. Carling D. (2004). Trends Biochem. Sci., 29, 18-24.
20. Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, Tsichlis PN, Cantley LC, Roberts TM and Vogt PK. (1997). Science, 276, 1848-1850.
21. Cheng JQ, Altomare DA, Klein MA, Lee W-C, Kruh GD, Lissy NA and Testa JR. (1997). Oncogene, 14, 2793-2801.
22. Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN and Testa JR. (1992). Proc. Natl. Acad. Sci. USA, 89, 9267-9271.
23. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK and Testa JR. (1996). Proc. Natl. Acad. Sci. USA, 93, 3636-3641.
24. Cheng JQ, Lindsley CW, Cheng GZ, Yang H and Nicosia SV. (2005). Oncogene Rev., 24, 7482-7492.
25. deGraffenried LA, Friedrichs WE, Russell DH, Donzis EJ, Middleton AK, Silva JM, Roth RA and Hidalgo M. (2004). Clin. Cancer Res., 10, 8059-8067.
26. Di Cristofano A and Pandolfi PP. (2000). Cell, 100, 387-390.
27. Di Cristofano A, Pesce B, Cordon-Cardo C and Pandolfi PP. (1998). Nat. Genet., 19, 348-355.
28. Downward J. (2004). Semin. Cell. Dev. Biol., 15, 177-182.
29. Eng C. (2003). Hum. Mutat., 22, 183-198.
30. Greer EL and Brunet A. (2005). Oncogene Rev., 24, 7410-7425.
31. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN and Larue L. (2003). Cancer Res., 63, 2172-2178.
32. Hanahan D and Weinberg RA. (2000). Cell, 100, 57-70.
33. Hu L, Hofmann J, Lu Y, Mills GB and Jaffe RB. (2002). Cancer Res., 62, 1087-1092.
34. Inoki K, Corradetti MN and Guan KL. (2005). Nat. Genet., 37, 19-24.
35. Inoki K, Zhu T and Guan KL. (2003). Cell, 115, 577-590.
36. Johannessen CM, Reczek EE, James MF, Brems H, Legius E and Cichowski K. (2005). Proc. Natl. Acad. Sci. USA, 102, 8573-8578.
37. Jucker M, Sudel K, Horn S, Sickel M, Wegner W, Fiedler W and Feldman RA. (2002). Leukemia, 16, 894-901.
38. Kang S, Bader AG and Vogt PK. (2005). Proc. Natl. Acad. Sci. USA, 102, 802-807.
39. Kenerson HL, Aicher LD, True LD and Yeung RS. (2002). Cancer Res., 62, 5645-5650.
40. Kim WY and Kaelin WG. (2004). J. Clin. Oncol., 22, 4991-5004.
41. Knobbe CB and Reifenberger G. (2003). Brain Pathol., 13, 507-518.
42. Kumar CC and Madison V. (2005). Oncogene Rev., 24, 7493-7454.
43. Kwiatkowski DJ. (2003). Ann. Hum. Genet., 67, 87-96.
44. Larue L and Bellacosa A. (2005). Oncogene Rev., 24, 7443-7454.
45. Lefranc F, Brotchi J and Kiss R. (2005). J. Clin. Oncol., 23, 2411-2422.
46. Lian Z and Di Cristofano A. (2005). Oncogene Rev., 24, 7394-7400.
47. Liang J and Slingerland JM. (2003). Cell Cycle, 2, 339-345.
48. Liu JP. (1999). FASEB J., 13, 2091-2104.
49. Liu AX, Testa JR, Hamilton TC, Jove R, Nicosia SV and Cheng JQ. (1998). Cancer Res., 58, 2973-2977.
50. Luo J, Manning BD and Cantley LC. (2003). Cancer Cell, 4, 257-262.
51. Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, Manola J, Brugarolas J, McDonnell TJ, Golub TR, Loda M, Lane HA and Sellers WR. (2004). Nat. Med., 10, 594-601.
52. Majumder PK, Yeh JJ, George DJ, Febbo PG, Kum J, Xue Q, Bikoff R, Ma H, Kantoff PW, Golub TR, Loda M and Sellers WR. (2003). Proc. Natl. Acad. Sci. USA, 100, 7841-7846.
53. Majumder PK and Sellers WR. (2005). Oncogene Rev., 24, 7465-7474.
54. Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW and Sonenberg N. (2004). Oncogene, 23, 3172-3179.
55. Mayo LD and Donner DB. (2002). Trends Biochem. Sci.,, 27, 462-467.
56. Mitsiades CS, Mitsiades N and Koutsilieris M. (2004). Curr. Cancer Drug Targets, 4, 235-256.
57. Miwa W, Yasuda J, Murakami Y, Yashima K, Sugano K, Sekine T, Kono A, Egawa S, Yamaguchi K, Hayashizaki Y and Sekiya T. (1996). Biochem. Biophys. Res. Commun., 225, 968-974.
58. Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN and Rosen N. (1998). J. Biol. Chem., 273, 29864-29872.
59. Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ and Roth RA. (1999). J. Biol. Chem., 274, 21528-21532.
60. Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R, Frost P, Gibbons JJ, Wu H and Sawyers CL. (2001). Proc. Natl. Acad. Sci. USA, 98, 10314-10319.
61. Page C, Lin HJ, Jin Y, Castle VP, Nunez G, Huang M and Lin J. (2000). Anticancer Res., 20, 407-416.
62. Pedrero JM, Carracedo DG, Pinto CM, Zapatero AH, Rodrigo JP, Nieto CS and Gonzalez MV. (2005). Int. J. Cancer, 114, 242-248.
63. Philp AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH, Thomas RJ and Phillips WA. (2001). Cancer Res., 61, 7426-7429.
64. Plas DR and Thompson CB. (2005). Oncogene Rev., 24, 7435-7442.
65. Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J, Neshat M, Wang H, Yang L, Gibbons J, Frost P, Dreisbach V, Blenis J, Gaciong Z, Fisher P, Sawyers C, Hedrick-Ellenson L and Parsons R. (2001). Proc. Natl. Acad. Sci. USA, 98, 10320-10325.
66. Pommier Y, Sordet O, Antony S, Hayward RL and Kohn KW. (2004). Oncogene, 23, 2934-2949.
67. Robertson GP. (2005). Cancer Met Rev., 24, 273-285.
68. Roy HK, Olusola BF, Clemens DL, Karolski WJ, Ratashak A, Lynch HT and Smyrk TC. (2002). Carcinogenesis, 23, 201-205.
69. Ruggeri BA, Huang L, Wood M, Cheng JQ and Testa JR. (1998). Mol. Carc., 21, 81-86.
70. Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C and Pandolfi PP. (2004). Nat. Med., 10, 484-486.
71. Ruggero D and Pandolfi PP. (2003). Nat. Rev. Cancer, 3, 179-192.
72. Ruggero D and Sonenberg N. (2005). Oncogene Rev., 24, 7426-7434.
73. Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, Yu JS, Malmstrom PO, Mansukhani M, Enoksson J, Hibshoosh H, Borg A and Parsons R. (2005). Cancer Res., 65, 2554-2559.
74. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B and Velculescu VE. (2004). Science, 304, 554.
75. Sansal I and Sellers WR. (2004). J. Clin. Oncol., 22, 2954-2963.
76. Scheid MP and Woodgett JR. (2003). FEBS Lett., 546, 108-112.
77. Schlegel J, Piontek G and Mennel HD. (2002). Anticancer Res., 22, 2837-2840.
78. Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA and Cantley LC. (2004). Cancer Cell, 6, 91-99.
79. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB and Gray JW. (1999). Nat. Genet., 21, 99-102.
80. Shiojima I and Walsh K. (2002). Circ. Res., 90, 1243-1250.
81. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN and Calabretta B. (1997). EMBO J., 16, 6151-6161.
82. Slupianek A, Nieborowska-Skorska M, Hoser G, Morrione A, Majewski M, Xue L, Morris SW, Wasik MA and Skorski T. (2001). Cancer Res., 61, 2194-2199.
83. Sordella R, Bell DW, Haber DA and Setteman J. (2004). Science, 305, 1163-1167.
84. Staal SP. (1987). Proc. Natl. Acad Sci. USA, 84, 5034-5037.
85. Stal O, Perez-Tenorio G, Akerberg L, Olsson B, Nordenskjold B, Skoog L and Rutqvist LE. (2003). Breast Cancer Res., 5, R37-R44.
86. Sun M, Wang G, Paciga JE, Feldman RI, Yuan ZQ, Ma XL, Shelley SA, Jove R, Tsichlis PN, Nicosia SV and Cheng JQ. (2001). Am. J. Pathol., 159, 431-437.
87. Sun S and Steinberg BM. (2002). J. Gen. Virol., 83, 1651-1658.
88. Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH and Testa JR. (2001). Cancer Res., 61, 589-593.
89. Terakawa N, Kanamori Y and Yoshida S. (2003). Endocr. Relat. Cancer, 10, 203-208.
90. Testa JR and Bellacosa A. (2001). Proc. Natl. Acad. Sci. USA, 98, 10983-10985.
91. Thant AA, Nawa A, Kikkawa F, Ichigotani Y, Zhang Y, Sein TT, Amin AR and Hamaguchi M. (2000). Clin. Exp. Metastasis, 18, 423-428.
92. Thompson FH, Nelson MA, Trent JM, Guan XY, Liu Y, Yang JM, Emerson J, Adair L, Wymer J, Balfour C, Massey K, Weinstein R, Alberts DS and Taetle R. (1996). Cancer Genet. Cytogenet., 87, 55-62.
93. Tsao AS, McDonnell T, Lam S, Putnam JB, Bekele N, Hong WK and Kurie JM. (2003). Cancer Epidemiol Biomarkers Prev., 12, 660-664.
94. Tucker M, Goldstein A, Dean M and Knudson A. (2000). J. Natl. Cancer Inst., 92, 530-533.
95. Waldmann V, Wacker J and Deichmann M. (2001). Arch. Dermatol. Res., 293, 368-372.
96. Wendel HG, DeStanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J and Lowe SW. (2004). Nature, 428, 267-269.
97. Whang YE, Yuan XJ, Liu Y, Majumder S and Lewis TD. (2004). Vitamins Hormones, 67, 409-426.
98. Whiteman EL, Cho H and Birnbaum MJ. (2002). Trends Endocrinol. Metab., 13, 444-451.
99. Xu X, Sakon M, Nagano H, Hiraoka N, Yamamoto H, Hayashi N, Dono K, Nakamori S, Umeshita K, Ito Y, Matsuura N and Monden M. (2004). Oncol. Rep., 11, 25-32.
100. Yang L, Dan HC, Sun M, Liu QY, Sun XM, Feldman RI, Hamilton AD, Polokoff M, Nicosia SV, Herlyn M, Sebti SM and Cheng JQ. (2004). Cancer Res., 64, 4394-4399.
101. Yuan ZQ, Sun M, Feldman RI, Wang G, Ma X, Jiang C, Coppola D, Nicosia SV and Cheng JQ. (2000). Oncogene, 19, 2324-2330.
102. Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N, Vazquez F, Carpenter CL and Kwiatkowski DJ. (2003). J. Clin. Invest., 112, 1223-1233.
103. Zhou BP and Hung MC. (2002). Semin. Oncol., 29, 62-70.